| Linnea Erica Malm, CNM | |
|
3 Alumni Dr Ste 401, Exeter, NH 03833-2123 | |
| (603) 778-0557 | |
| (603) 778-1669 |
| Full Name | Linnea Erica Malm |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 3 Alumni Dr Ste 401, Exeter, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316715386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 092725-23 (New Hampshire) | Primary |
| Entity Name | Core Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336330588 PECOS PAC ID: 2769563253 Enrollment ID: O20080123000205 |
News Archive
New research has found that children and youth may be at low risk of severe acute COVID-19, according to a study conducted during the first half of the pandemic and published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.210053.
On the surface, the thick, red, scaly, itchy plaques of psoriasis - which have been shown to have a significant negative impact on a person's overall quality of life - may not appear to pose a serious health risk for patients. However, a growing body of research suggests that psoriasis patients are at an increased risk of developing serious medical conditions, including cardiovascular disease and diabetes, particularly when their psoriasis is severe.
Star Scientific announced today that it has completed a "Research and Royalty Agreement" with the Roskamp Institute's affiliate, SRQ Bio, LLC, under which the Institute will conduct research on a compound developed by the company's Rock Creek Pharmaceutical subsidiary that medical researchers at the Institute believe may have an application in the treatment of Alzheimer's disease.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the pharmacokinetic results of their single dose Phase 1 study with RXI-109 in healthy subjects.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Linnea Erica Malm, CNM 398 Main St Apt C, South Berwick, ME 03908-1332 Ph: (603) 957-0533 | Linnea Erica Malm, CNM 3 Alumni Dr Ste 401, Exeter, NH 03833-2123 Ph: (603) 778-0557 |
News Archive
New research has found that children and youth may be at low risk of severe acute COVID-19, according to a study conducted during the first half of the pandemic and published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.210053.
On the surface, the thick, red, scaly, itchy plaques of psoriasis - which have been shown to have a significant negative impact on a person's overall quality of life - may not appear to pose a serious health risk for patients. However, a growing body of research suggests that psoriasis patients are at an increased risk of developing serious medical conditions, including cardiovascular disease and diabetes, particularly when their psoriasis is severe.
Star Scientific announced today that it has completed a "Research and Royalty Agreement" with the Roskamp Institute's affiliate, SRQ Bio, LLC, under which the Institute will conduct research on a compound developed by the company's Rock Creek Pharmaceutical subsidiary that medical researchers at the Institute believe may have an application in the treatment of Alzheimer's disease.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the pharmacokinetic results of their single dose Phase 1 study with RXI-109 in healthy subjects.
› Verified 3 days ago
Courtney E Coffey, APRN-CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3 Alumni Dr Ste 401, Exeter, NH 03833 Phone: 603-778-0557 Fax: 603-778-1669 |